NO20052979D0 - Propargyl trifluoromethoxy-amino-benzothiazole. - Google Patents

Propargyl trifluoromethoxy-amino-benzothiazole.

Info

Publication number
NO20052979D0
NO20052979D0 NO20052979A NO20052979A NO20052979D0 NO 20052979 D0 NO20052979 D0 NO 20052979D0 NO 20052979 A NO20052979 A NO 20052979A NO 20052979 A NO20052979 A NO 20052979A NO 20052979 D0 NO20052979 D0 NO 20052979D0
Authority
NO
Norway
Prior art keywords
propargyl
benzothiazole
trifluoromethoxy
amino
propargyl trifluoromethoxy
Prior art date
Application number
NO20052979A
Other languages
Norwegian (no)
Other versions
NO20052979L (en
Inventor
Yaacov Herzig
Jeffrey Sterling
Liat Hayardeny
Eliezer Falb
Eran Blaugrund
David Lerner
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20052979D0 publication Critical patent/NO20052979D0/en
Publication of NO20052979L publication Critical patent/NO20052979L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
NO20052979A 2002-11-21 2005-06-17 Propargyl trifluoromethoxy-amino-benzothiazole. NO20052979L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30154002A 2002-11-21 2002-11-21
PCT/US2003/037592 WO2004047756A2 (en) 2002-11-21 2003-11-20 Propargyl-trifluoromethoxy-amino-benzothiazole derivatives

Publications (2)

Publication Number Publication Date
NO20052979D0 true NO20052979D0 (en) 2005-06-17
NO20052979L NO20052979L (en) 2005-08-19

Family

ID=32392394

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052979A NO20052979L (en) 2002-11-21 2005-06-17 Propargyl trifluoromethoxy-amino-benzothiazole.

Country Status (13)

Country Link
EP (1) EP1569641A2 (en)
JP (1) JP2006507350A (en)
KR (1) KR20050083951A (en)
CN (1) CN1741802A (en)
AU (1) AU2003295898A1 (en)
BR (1) BR0315704A (en)
CA (1) CA2507414A1 (en)
IS (1) IS7906A (en)
MX (1) MXPA05005414A (en)
NO (1) NO20052979L (en)
RU (1) RU2005119307A (en)
WO (1) WO2004047756A2 (en)
ZA (1) ZA200504988B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012050971A2 (en) * 2010-09-29 2012-04-19 Teva Pharmaceutical Industries Ltd. Propargyl-trifluoromethoxy-aminobenzothiazole derivatives, their preparation and use
CN103340859A (en) * 2013-06-04 2013-10-09 中国科学院昆明动物研究所 Method for establishing non-human primate animal model of parkinson disease by lateral ventricle administration of MPP<+>

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59112978A (en) * 1982-12-21 1984-06-29 Shionogi & Co Ltd Propynylaminothiazole derivative

Also Published As

Publication number Publication date
ZA200504988B (en) 2006-08-30
JP2006507350A (en) 2006-03-02
WO2004047756A2 (en) 2004-06-10
RU2005119307A (en) 2006-01-27
CN1741802A (en) 2006-03-01
MXPA05005414A (en) 2006-05-25
BR0315704A (en) 2005-09-06
IS7906A (en) 2005-06-22
EP1569641A2 (en) 2005-09-07
KR20050083951A (en) 2005-08-26
NO20052979L (en) 2005-08-19
AU2003295898A1 (en) 2004-06-18
CA2507414A1 (en) 2004-06-10
WO2004047756A3 (en) 2004-07-08

Similar Documents

Publication Publication Date Title
NO20053248D0 (en) Kerosenblanding.
NO20052248D0 (en) Svivelstykkesystem.
DE60305332D1 (en) IMIDAZOi1,2-AöPYRIDINE
NO20051500D0 (en) Substituted heterocyclylpyrimidines.
NO20051497D0 (en) Beta-laktamaseinhibitorprodrug.
ITMI20032170A1 (en) TAGLIACIMOSSE.
FR2855029B1 (en) CACHE-POT.
ITMI20030916A1 (en) HAND.
NO20052979D0 (en) Propargyl trifluoromethoxy-amino-benzothiazole.
ITRM20020470A0 (en) WASHROOM.
ES1055830Y (en) MOSQUITERA
ES1052590Y (en) Kiosk-SET.
ES1052938Y (en) CANTONERA.
ES1052945Y (en) COUNTERWINDOW.
ES1051110Y (en) BOX-PALLET.
ES1051605Y (en) CHROME-PUZZLE.
ES1052654Y (en) CUBITERA
ES1052029Y (en) BALL-PROJECTILE.
ES1052011Y (en) SPETERO.
ES1051703Y (en) POTERA.
ITVI20020277A1 (en) SALVAPENNE.
ITTO20020864A1 (en) SALVAPOLSINO.
ITVE20020013U1 (en) BLOCCALACCIO.
ITRM20020034A1 (en) FIOCCHETTATRICE.
NL1020250A1 (en) Stelwig.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application